In the first scenario, knockdown of ZRF1 in ER (+) cells would promote a mixed epithelial-mesenchymal phenotype [30], most probably due to the high heterogeneity of breast cancer cells [72]. The gene discussed is DNAJC2; the disease is breast carcinoma.